This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1lp9
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:1lp9. | + | {{Seed}} |
| + | [[Image:1lp9.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 9: | Line 10: | ||
{{STRUCTURE_1lp9| PDB=1lp9 | SCENE= }} | {{STRUCTURE_1lp9| PDB=1lp9 | SCENE= }} | ||
| - | + | ===Xenoreactive complex AHIII 12.2 TCR bound to p1049/HLA-A2.1=== | |
| - | + | <!-- | |
| - | + | The line below this paragraph, {{ABSTRACT_PUBMED_14563323}}, adds the Publication Abstract to the page | |
| + | (as it appears on PubMed at http://www.pubmed.gov), where 14563323 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_14563323}} | ||
==Disease== | ==Disease== | ||
| Line 33: | Line 37: | ||
[[Category: Class i mhc:tcr co-crystal]] | [[Category: Class i mhc:tcr co-crystal]] | ||
[[Category: Immunoregulatory complex]] | [[Category: Immunoregulatory complex]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 21:42:24 2008'' | ||
Revision as of 18:42, 2 July 2008
Contents |
Xenoreactive complex AHIII 12.2 TCR bound to p1049/HLA-A2.1
Template:ABSTRACT PUBMED 14563323
Disease
Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]
About this Structure
1LP9 is a Protein complex structure of sequences from Homo sapiens and Mus musculus. Full crystallographic information is available from OCA.
Reference
A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection., Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ, Immunity. 2003 Oct;19(4):595-606. PMID:14563323
Page seeded by OCA on Wed Jul 2 21:42:24 2008
